Home/Filings/4/0001213900-26-002906
4//SEC Filing

Santos da Silva Jorge 4

Accession 0001213900-26-002906

CIK 0001821586other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:01 PM ET

Size

5.6 KB

Accession

0001213900-26-002906

Insider Transaction Report

Form 4
Period: 2026-01-07
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-07+520,342520,342 total
    Exercise: $11.29Exp: 2036-01-07Class A ordinary shares, par value $0.0001 per share (520,342 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 520,342 of the Issuer's Class A ordinary shares, vesting in four equal annual installments on January 7, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Documents

1 file

Issuer

MoonLake Immunotherapeutics

CIK 0001821586

Entity typeother

Related Parties

1
  • filerCIK 0001920509

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:01 PM ET
Size
5.6 KB